secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2024-06-07T23:59:59+00:00
Accession:  0001005286-24-000077
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifecore receives Nasdaq delisting notice for missing annual meeting and filing delays
--------------------------------------------------------------------------------

- Nasdaq notified Lifecore on June 3, 2024 of non-compliance with listing rules.
- Failure to hold 2023 annual meeting within 12 months of fiscal year-end (May 28, 2023) triggered Rule 5620(a).
- Delays in filing Q1, Q2, and Q3 FY2024 Forms 10-Q violate Rules 5810(c)(2)(G) and 5250(c)(1).
- Company has scheduled 2023 annual meeting for August 15, 2024 and will request extension from Nasdaq Hearings Panel.
- Nasdaq previously granted stay; delisting decision is pending; no immediate effect on stock trading.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000077/0001005286-24-000077-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000077/lndc-20240603.htm
  HTML page:      https://secwatch.observer/filing/0001005286-24-000077

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer